Innovation Pharmaceuticals Inc (IPIX)

[RJFL]

Hi Govorchin,

Thanks for the nice note, so sorry to see the degree cancer has impacted your family/loved ones. It certainly reaffirms the need to stay well read on new developments/research in the oncology arena. I know I try to be well read due to my daughter but fortunately she is as well since she is a nurse. As for our current Kevetrin trial, I am hopeful we get a similar update at this years ASCO as we did last year. Imagine if they can report multiple patients with "tumor regression" by that juncture since additional cohort information will be available. That will open eyes for sure. I also agree the fact that the Univ. of Bologna is moving forward with their study prior to completion of the Phase I at DF speaks volume since it appears they feel they have enough information now so why wait (plus they probably have access to additional info).

One other point I wanted to toss out to the forum here concerns the potential for some of the other assets Cellceutix acquired in the Polymedix fire sale such as the PolyCide Antimicrobial in Surgical Suture Coatings application. The link below shows it had very favorable results in their study. I have been unable to determine what the market might be for this application. Thoughts anyone..... The use of antimicrobial coating technology on other surfaces also is of interest to me since my profession (industrial hygiene/health and safety) takes me in to hospital settings where hospital acquired/nosocomial infections are a big problem. The fruition of this type application/technology may be many years away but imagine developing surfaces that inhibit microbial contamination, the applications, and inmplications are vast.....

http://globenewswire.com/news-release/2012/09/05/488925/10004018/en/Data-Showing-Effectiveness-of-PolyCide-Antimicrobial-in-Surgical-Suture-Coatings-Published-in-American-Chemical-Society-Journal-Langmuir.html